secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001437749-25-008869
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene reports FY2024 net loss $39.4M ($5.67/sh); plans NDA for CNM-Au8 in ALS in H2 2025
--------------------------------------------------------------------------------

- Net loss $39.4M ($5.67/sh) vs. $49.5M ($9.43/sh) in FY2023.
- Cash and marketable securities $12.2M at Dec 31, 2024; expected to fund ops into Q2 2025.
- R&D expense $20.1M, down 25% YoY; G&A $13.3M, down 8%.
- Planning NDA submission for CNM-Au8 in ALS in H2 2025; confirmatory Phase 3 RESTORE-ALS starts mid-2025.
- Secured new $10M debt facility (12% interest, convertible at $5.67) replacing $7.85M Avenue debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000143774925008869/0001437749-25-008869-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000143774925008869/clnn20240924_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-008869

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer